Medical corporation Suiseikai Suiseikai Kajikawa Hospital

Hiroshima, Hiroshima 730-0046

0 studies enrolling now · 1 studies all time

What they study most

Secondary Prevention, Stroke

Studies at this site

• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed